Gene therapy with AAV2/8-LSPhGAA shows good results in preclinical Pompe disease
Feb. 19, 2024
Pompe disease is a disorder caused by deficiency of the lysosomal acid α-glucosidase (GAA) enzyme, which leads to the accumulation of glycogen within the lysosomes, overall in skeletal and cardiac muscle.